You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 1
  • 4CPS-146 ‘Real world’ experience ofelexacaftor/tezacaftor/ivacaftor in the treatment of cystic fibrosis: effectiveness and safety evaluation

Article info

Article menu

Download PDFPDF

Section 4: Clinical pharmacy services
4CPS-146 ‘Real world’ experience ofelexacaftor/tezacaftor/ivacaftor in the treatment of cystic fibrosis: effectiveness and safety evaluation
Free

Authors

Citation

Fernandez Cuerva C, Paradas Palomo J, Chinchilla Alarcon T, et al
4CPS-146 ‘Real world’ experience ofelexacaftor/tezacaftor/ivacaftor in the treatment of cystic fibrosis: effectiveness and safety evaluation
European Journal of Hospital Pharmacy 2023;30:A71.

Publication history

  • First published March 23, 2023.
Online issue publication 
May 02, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© European Association of Hospital Pharmacists 2023. No commercial re-use. See rights and permissions. Published by BMJ.